Electromed, Inc.

AMEX:ELMD

Medical - Devices

Healthcare
$23.26 +1.16%

+$0.43 today

Market cap
$190.13M
Beta
0.52
P/E (TTM)
30.5
EPS (TTM)
$1.23
52W Low $17.73High $40.00

Volume 0.05M

Average 0.06M

Big Five Numbers

Electromed, Inc. growth analysis

Start with the long-run numbers that show whether ELMD compounds: return on capital and growth in sales, earnings, equity, and free cash flow.

Big Five Numbers

CAGR by period · ROIC shows average

Metric 10yr 5yr3yr1yr
EPS
Not availableNot available+49.0%+48.3%
Revenue
Not availableNot available+15.4%+17.0%
Equity
Not availableNot available+8.7%-0.4%
Cash
Not availableNot available+23.3%-4.9%
ROIC
Not available9.9%11.9%16.7%

Analysis

In the latest year, EPS was strongest at +48.3%, while Cash was weakest at -4.9%. The three-year average ROIC was 11.9%, a measure of how efficiently the company earned that growth.

Growth analysis

Is growth accelerating or fading?

Compare historical growth with analyst forecasts across revenue, earnings, and cash flow.

Growth Analysis

Historical CAGR & forward analyst estimates

Metric 10yr 5yr3yr Fwd Est.
EPSN/AN/A+49.0%
+6.0% (5yr)1 analysts
RevenueN/AN/A+15.4%
+6.0% (5yr)1 analysts
Net IncomeN/AN/A+48.4%
+5.8% (5yr)1 analysts
EBITN/AN/A+49.2%
+5.9% (5yr)1 analysts

Analysis

Recent growth has been strongest in EBIT at +49.2% over three years. Forward estimates point to Revenue at +6.0% (5yr), giving you a quick check on whether expectations are accelerating or cooling.

Revenue segments

Where does the growth come from?

Break revenue down by product and geography to see which parts of the business drive the trend.

Revenue by segment

Where ELMD earns its revenue, as reported in company filings

  • Home Care
  • Other
  • Institutional
  • Shipping and Handling
  • International1Member
  • Capital Stock
  • Other
Revenue by segment for FY2024
Segment · FY2024 Revenue Share YoY
Home Care$841K50.4%-52.8%
Other$826K49.6%—
Other$826K49.6%—

Figures in USD. Segments account for 3.0% of reported FY2024 revenue; $53.05M is not attributed to a segment. Smaller segments are grouped as "Other".

Free cash flow

Does growth turn into cash?

Check whether reported growth converts into free cash flow after capital spending.

Free Cash Flow

Net Income to FCF bridge

Cash Flow Statement

FY2025

= Net Income$7.5M
+ D&A$1.2M
+ Stock-Based Comp$3.1M
- Deferred Tax-$310.0K
- Working Capital-$277.0K
+ Other Non-Cash$212.0K
= Operating Cash Flow$11.4M
- Capex-$306.0K
= Free Cash Flow$11.1M

Analysis

FY2025 free cash flow is $11.1M. FCF conversion is 147.1% of net income. Operating cash flow was $11.4M, with capex of -$306.0K. The largest bridge item is Stock-Based Comp at $3.1M.

Price targets

What do analysts expect from the price?

Compare the current price with the low, average, and high analyst targets.

Wall Street price targets

1-year price history with analyst consensus target

Growth

Unlock analyst target range

Sign in free to see low, average, high targets and implied upside for ELMD.

Sign in free

Analyst ratings

How do analysts rate the stock?

Review the buy, hold, and sell split and recent upgrades and downgrades.

Analyst ratings

Buy, hold, and sell recommendations and recent rating changes

Unlock analyst ratings

Sign in free to see the buy/hold/sell breakdown and recent rating changes for ELMD.

Sign in free

Competitor growth

How does Electromed, Inc. grow against peers?

Compare historical and forecast growth with similar companies.

Competitor Growth

Peer CAGR comparison & forward estimates

CompanyMarket Cap10yr5yr3yrFwd

ResMed Inc.

RMD

$33.69B+11.9%+12.1%+10.2%
+5.7% (4yr)19 analysts

AdaptHealth Corp.

AHCO

$1.05B—+25.2%+3.0%
+14.1% (5yr)3 analysts

Tactile Systems Technology, Inc.

TCMD

$600.58M+18.0%+12.0%+10.1%
+9.2% (3yr)3 analysts

Viemed Healthcare, Inc.

VMD

$347.48M+22.8%+15.5%+24.9%
+12.2% (3yr)2 analysts

Pulmonx Corporation

LUNG

$124.55M—+22.6%+19.0%
+8.5% (5yr)2 analysts

Questions

Growth questions

Common questions about ELMD's growth, answered from reported and forecast figures.

Is ELMD growing revenue?

Revenue grew 17.0% year over year, from $54.72M to $64.00M.

Is ELMD turning growth into profit?

The latest net margin is 11.8%, which shows how much revenue became net income.